---
$id: https://graph.org.ai/products/commodity/51131629
$type: Product
source: UNSPSC
code: "51131629"
title: "Clopidogrel"
class: "51131600"
classTitle: "Anticoagulants"
family: "51130000"
familyTitle: "Hematolic drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clopidogrel

**UNSPSC Code**: 51131629
**Class**: [Anticoagulants](Anticoagulants.mdx)
**Family**: [Hematolic drugs](../Hematolic drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a thienopyridine antiplatelet agent with the molecular formula C16H16ClNO2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A74586SNO7, chemically known as thieno(3,2-c)pyridine-5(4h)-acetic acid, alpha-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (s)- but generally known as clopidogrel, which bears US NIH Compound Identifier 60606. European Medicines Agency schedules Clopidogrel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13395MIG. World Health Organization schedules clopidogrel in its Anatomical Therapeutic Chemical (ATC) Classification. CLOPIDOGREL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clopidogrel under HS 29349990 and SITC 51579. As of Q4 2014, CLOPIDOGREL remains the US FDA Preferred Term for this commodity. Clopidogrel bears US NLM identifiers UMLS ID C0070166 and NCI Concept Code C61686. SMILES: CLC1C(C(N2CCC3SCCC3C2)C(=O)OC)CCCC1.

